Sign in

NCT06331767Not yet recruiting

Development of a Multilevel HIV Prevention Intervention for the Emergency Department

mSYNC: an mHealth SYNdemic-based Consultation-liaison HIV Prevention Intervention for the Emergency Department

Source: ClinicalTrials.gov · Last updated 9 Jul 2026

Brief summary (registry, in English)

The goal of this clinical trial is to pilot test a psychosocial-behavioral mobile health (mHealth) human immunodeficiency virus (HIV) prevention intervention in people who use drugs presenting to the emergency department (ED). The main question the study aims to answer is: is the intervention acceptable and appropriate? Participants will use the mHealth app while waiting in the ED and also at home for 90 days. Participants will be asked to complete surveys at baseline, before leaving the ED, and at 30-, 60-, and 90-day follow up visits.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
18 Mar 2024
Start date
Sept 2026
Primary completion date
Apr 2029
Lead sponsor
Brigham and Women's Hospital
Diseases
HIV
NCT number
NCT06331767

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From Sept 2026 to the primary completion date, Apr 2029
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Medical or psychiatric condition that would interfere with ability to participate in study procedures
  • Presented to the emergency department (ED) for a psychiatric issue

Other

  • Unable to provide informed consent
  • Expected to be admitted to ED for more than 48 hours

Who the study is looking for

  • At least 18 years old
  • No HIV positive test in electronic medical record or self-reported
  • Past month HIV risk behavior (condomless sex or needle sharing not protected by adherent PrEP \[pre-exposure prophylaxis\])
  • Past month use of illicit drugs (excluding marijuana)
  • Belong to at least one of key HIV risk group (transgender woman, MSM, Black/Latinx/Indigenous)
  • Own a smartphone
  • Able to read and understand English

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.